Roche Products India Pvt Ltd
Ado-trastuzumab emtansine (100mg)
Kadcyla 100mg Injection is used to treat early as well as metastatic breast cancer, specifically HER-2 positive breast cancer that has spread to other organs and has not responded to other cancer medicines.
Injection
Kadcyla 100mg Injection is an anti-cancer medicine used to treat certain types of breast cancer (human epidermal growth factor receptor 2, HER-2) which have spread to other organs and have not responded to other cancer medicines. It is given via a drip into a vein (intravenous infusion) under the supervision of a doctor.
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
Kadcyla 100mg Injection is an anti-cancer medicine that binds to HER2 receptors on breast cancer cells and flags the cancer cells for destruction by the body's immune system. It also goes into the cancer cells to release a chemotherapy medicine (emtansine) and stop them from growing and dividing.
Do not skip any dose and complete the course as suggested by your doctor Your doctor may check your liver function before starting treatment and regularly thereafter Women who could get pregnant should use a reliable method of contraception to prevent pregnancy while taking this medicine Regular monitoring of heart function (tests like echocardiogram) and blood tests to monitor the level of blood cells may be advised before starting treatment and regularly during treatment with Kadcyla 100mg Injection
Kadcyla 100mg Injection is used to treat HER2-positive metastatic breast cancer after prior treatment with trastuzumab and a taxane.
Kadcyla 100mg Injection is a combination of the HER2-directed monoclonal antibody trastuzumab and the highly toxic microtubule-targeted drug emtansine. This unique formulation brings chemotherapy medicine (emtansine) directly into HER2-positive cells, leading to their destruction, while minimizing damage to normal cells.